Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 55 min ago
Peer-reviewedCC BY 4.0JMIR Aging

Temporal Trends in the Prevalence of Frailty in England From 2002 to 2022, With Forecasts to 2040: Longitudinal Secondary Analysis of a National Cohort Study

7 affiliations
  1. 1School of Life Course and Population Sciences, Faculty of Life Science and Medicine, King's College London, Great Maze Pond, Guy's Campus, London, England, SE1 1UL, United Kingdom, 44 07522762135
  2. 2Center for Bone & Joint Health, Blizard Institute, Queen Mary University of London, London, England, United Kingdom
  3. 3Medical Research Council Unit for Lifelong Health and Ageing, University College London, London, England, United Kingdom
  4. 4Royal London Hospital, London, England, United Kingdom
  5. 5Wolfson Institute of Population Health, Queen Mary University of London, London, England, United Kingdom
  6. 6Department of Clinical Gerontology, King's College Hospital NHS Foundation Trust, London, England, United Kingdom
  7. 7NIHR Applied Research Collaboration (ARC) South London, London, England, United Kingdom

Abstract

Background: The increasing life expectancy provides an opportunity for healthy longevity, but frailty is a potential challenge. Existing studies of frailty prevalence in England are largely cross-sectional, use heterogeneous frailty definitions, and rarely break down population-level drivers or project future burden, limiting their use for health and social care planning.

Objective: This study aimed to explore temporal trends of frailty prevalence and project scenario-based future prevalence up to 2040 for the community-dwelling population aged 50 years and older in England.

Methods: Prevalence of frailty (measured using a frailty index) in the overall sample and subgroups of age, sex, educational level, and marital status from 2002 to 2022 was estimated among the community-dwelling population aged 50 years and older using 10 waves of nationally representative data from the English Longitudinal Study of Ageing (ELSA; n=6226 to 11,218 across waves). The number of individuals with frailty was also derived in each year. Joinpoint regression models were used to explore temporal trends of frailty prevalence. A linear probability regression model was performed using pooled data from 10 waves of the ELSA to explore driving factors and project future prevalence. Decomposition analysis was used to estimate the contribution of individual factors to the change in prevalence.

Results: A statistically nonsignificant (P=.61) increase of 2.3 percentage points from 15.5% (1738/11,218) in 2002 to 17.8% (1108/6226) in 2022 was observed, with the number of individuals with frailty growing from 2,560,122 to 3,791,038 among community-dwelling adults aged 50 years and older in England. Those with advanced age, who were female, had a lower educational level, and/or were single had a consistently higher prevalence of frailty. Opposing contributions netted to this overall change: improvements in sociodemographic conditions and educational attainment and healthier lifestyle behaviors offset 222.5%, 94.9%, and 51.6% of the observed increase, respectively. Under scenario-based projections, prevalence was estimated at 20.5% (95% CI 19.2%-21.9%) in 2040, corresponding to 5,213,689 people with frailty.

Conclusions: Despite a modest increase in prevalence among the community-dwelling population aged 50 years and older, the substantial growth in the absolute number of individuals with frailty indicates a likely rise in future care demands. The study contributes a 20-year trend, decomposition, and forecast framework for community-dwelling older adults. Findings support prioritizing broader sociodemographic development alongside educational attainment and healthy lifestyles, with potential policy approaches including income and social protection, housing improvements, access to health care, and prevention. Key limitations include self-reported measures, exclusion of care home residents, and potential influence of unmeasured effects.

Related

  1. Global, Regional, and National Burden of Bone Cancers, 1990 to 2023, With Forecasts to 2050
    GBD 2023 Bone Cancer Collaborators, Chalinee Monsereenusorn, Catherine Bisignano +282
    JAMA OncologyPeer-reviewedLicence not statedFull textOncologyPMC
  2. Global, regional and national burden of cervical cancer in 1990–2023 with forecasts to 2050: a Global Burden of Disease study
    GBD Collaborators, Natalie Pritchett, Miranda L. May +97
    Nature MedicinePeer-reviewedLicence not statedFull text14 citedEpidemiology & public healthOpenAlex
  3. Rising stroke burden in Uganda: A national time-series analysis and forecasts, 2016–2028
    Suzan Nakasendwa, Joan Nankya Mutyoba, Alex Riolexus Ario +7
    PLOS OnePeer-reviewedCC BY 4.0Full textStatisticsCardiovascular medicinePLOS
  4. The Epidemiology of Disability in Saudi Arabia: National Prevalence, Functional Multimorbidity, and Age-Stratified Self-Reported Causes
    Saad M. Bindawas, Vishal Vennu
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Prevalence of Sarcopenia in Korean Adults Based on the Asian Working Group for Sarcopenia 2025 Criteria: Analysis of the 2024 Korea National Health and Nutrition Examination Survey
    Jun-Il Yoo, Yonghan Cha, Deog-Yoon Kim +2
    Journal of Korean medical sciencePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
BibTeX
@article{tang2026temporal,
  title = {{Temporal Trends in the Prevalence of Frailty in England From 2002 to 2022, With Forecasts to 2040: Longitudinal Secondary Analysis of a National Cohort Study}},
  author = {Dongfeng Tang and Katie Jane Sheehan and Simon Conroy and Aicha Goubar and Julie Whitney and Yanzhong Wang and Matthew D L O'Connell},
  journal = {JMIR Aging},
  year = {2026},
  month = nov,
  doi = {10.2196/98665},
  url = {https://doi.org/10.2196/98665},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Temporal Trends in the Prevalence of Frailty in England From 2002 to 2022, With Forecasts to 2040: Longitudinal Secondary Analysis of a National Cohort Study
AU  - Dongfeng Tang
AU  - Katie Jane Sheehan
AU  - Simon Conroy
AU  - Aicha Goubar
AU  - Julie Whitney
AU  - Yanzhong Wang
AU  - Matthew D L O'Connell
PY  - 2026
DA  - 2026/11/03
JO  - JMIR Aging
DO  - 10.2196/98665
UR  - https://doi.org/10.2196/98665
AB  - Background: The increasing life expectancy provides an opportunity for healthy longevity, but frailty is a potential challenge. Existing studies of frailty prevalence in England are largely cross-sectional, use heterogeneous frailty definitions, and rarely break down population-level drivers or project future burden, limiting their use for health and social care planning.  Objective: This study aimed to explore temporal trends of frailty prevalence and project scenario-based future prevalence up to 2040 for the community-dwelling population aged 50 years and older in England.  Methods: Prevalence of frailty (measured using a frailty index) in the overall sample and subgroups of age, sex, educational level, and marital status from 2002 to 2022 was estimated among the community-dwelling population aged 50 years and older using 10 waves of nationally representative data from the English Longitudinal Study of Ageing (ELSA; n=6226 to 11,218 across waves). The number of individuals with frailty was also derived in each year. Joinpoint regression models were used to explore temporal trends of frailty prevalence. A linear probability regression model was performed using pooled data from 10 waves of the ELSA to explore driving factors and project future prevalence. Decomposition analysis was used to estimate the contribution of individual factors to the change in prevalence.  Results: A statistically nonsignificant (P=.61) increase of 2.3 percentage points from 15.5% (1738/11,218) in 2002 to 17.8% (1108/6226) in 2022 was observed, with the number of individuals with frailty growing from 2,560,122 to 3,791,038 among community-dwelling adults aged 50 years and older in England. Those with advanced age, who were female, had a lower educational level, and/or were single had a consistently higher prevalence of frailty. Opposing contributions netted to this overall change: improvements in sociodemographic conditions and educational attainment and healthier lifestyle behaviors offset 222.5%, 94.9%, and 51.6% of the observed increase, respectively. Under scenario-based projections, prevalence was estimated at 20.5% (95% CI 19.2%-21.9%) in 2040, corresponding to 5,213,689 people with frailty.  Conclusions: Despite a modest increase in prevalence among the community-dwelling population aged 50 years and older, the substantial growth in the absolute number of individuals with frailty indicates a likely rise in future care demands. The study contributes a 20-year trend, decomposition, and forecast framework for community-dwelling older adults. Findings support prioritizing broader sociodemographic development alongside educational attainment and healthy lifestyles, with potential policy approaches including income and social protection, housing improvements, access to health care, and prevention. Key limitations include self-reported measures, exclusion of care home residents, and potential influence of unmeasured effects.
SN  - 2561-7605
ER  -